Singapore-headquartered biotech firm Chitose Bio Evolution has announced rising 1 billion yen (about $6.2 million) in fresh investment from Japan’s Sumitomo Mitsui Banking Corp (SMBC).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
